A single-nucleotide polymorphism in a herpesvirus DNA polymerase is sufficient to cause lethal neurological disease.

Epidemiological studies have shown that a single-nucleotide polymorphism in the equid herpesvirus type 1 DNA polymerase gene is associated with outbreaks of highly lethal neurological disease in horses. Reverse genetics experiments further demonstrated that a G(2254) A(2254) nucleotide mutation introduced in neurovirulent strain Ab4, which resulted in an asparagine for aspartic acid substitution (D(752) N(752)), rendered the virus nonneurovirulent in the equine. Here, we report that the nonneurovirulent strain equid herpesvirus type 1 strain NY03 caused lethal neurological disease in horses after mutation of A(2254) G(2254) (N(752) D(752)), thereby providing final proof that the D(752) allele in the viral DNA polymerase is necessary and sufficient for expression of the lethal neurovirulent phenotype in the natural host. Although virus shedding was comparable between the N(752) and D(752) variants, infection with the latter was accompanied by efficient establishment of prolonged cell-associated viremia in peripheral blood mononuclear cells and neurological disease in 2 of 6 animals.

[1]  C. Carter,et al.  Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky. , 2008, Equine veterinary journal.

[2]  J. Casanova,et al.  Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans , 2007, Current opinion in allergy and clinical immunology.

[3]  G. Palù,et al.  A Point Mutation in a Herpesvirus Polymerase Determines Neuropathogenicity , 2007, PLoS pathogens.

[4]  Eric T Baldwin,et al.  Crystal Structure of the Herpes Simplex Virus 1 DNA Polymerase* , 2006, Journal of Biological Chemistry.

[5]  R. Bowden,et al.  Analysis of Equid Herpesvirus 1 Strain Variation Reveals a Point Mutation of the DNA Polymerase Strongly Associated with Neuropathogenic versus Nonneuropathogenic Disease Outbreaks , 2006, Journal of Virology.

[6]  J. von Einem,et al.  Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. , 2006, BioTechniques.

[7]  J. von Einem,et al.  Equine herpesvirus type 1 modified live virus vaccines: quo vaditis? , 2006, Expert review of vaccines.

[8]  Andrew J Davison,et al.  Evolution of the herpesviruses. , 2002, Veterinary microbiology.

[9]  N. Osterrieder,et al.  Equine herpesvirus type 1 devoid of gM and gp2 is severely impaired in virus egress but not direct cell-to-cell spread. , 2002, Virology.

[10]  N. Osterrieder,et al.  Cloning of the genomes of equine herpesvirus type 1 (EHV-1) strains KyA and racL11 as bacterial artificial chromosomes (BAC). , 2002, Journal of veterinary medicine. B, Infectious diseases and veterinary public health.

[11]  K. Tyler,et al.  A herpes simplex virus DNA polymerase mutation that specifically attenuates neurovirulence in mice. , 1998, Virology.

[12]  W. D. Wilson,et al.  Equine herpesvirus 1 myeloencephalopathy. , 1997, The Veterinary clinics of North America. Equine practice.

[13]  F. Lori,et al.  Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Coen,et al.  Engineered herpes simplex virus DNA polymerase point mutants: the most highly conserved region shared among alpha-like DNA polymerases is involved in substrate recognition , 1990, Journal of virology.

[15]  P Argos,et al.  An attempt to unify the structure of polymerases. , 1990, Protein engineering.

[16]  M. Hunkapiller,et al.  Human DNA polymerase alpha gene expression is cell proliferation dependent and its primary structure is similar to both prokaryotic and eukaryotic replicative DNA polymerases. , 1988, The EMBO journal.

[17]  D. Coen,et al.  Penciclovir and pathogenesis phenotypes of drug-resistant Herpes simplex virus mutants. , 1998, Antiviral research.

[18]  Bryans Jt,et al.  Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. , 1986 .